EMA
approval
· 2024-02-23
New treatment for rare motor neurone disease recommended for approval
Summary
The EMA recommends approval for a new treatment aimed at rarer forms of motor neuron disease, indicating a potential new option for patients with the condition.
Upgrade for the full analysis, importance score, and drug timeline.